Pain and Delirium in Critical Illness: An Exploration of Key 2018 SCCM PADIS Guideline Evidence Gaps

Margaret A. Pisani; John W. Devlin; Yoanna Skrobik

doi:10.1055/s-0039-1698809

Seminars in Respiratory and Critical Care Medicine, Table of Contents

Semin Respir Crit Care Med 2019; 40(05): 604-613
DOI: 10.1055/s-0039-1698809

Review Article

Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Pain and Delirium in Critical Illness: An Exploration of Key 2018 SCCM PADIS Guideline Evidence Gaps

Margaret A. Pisani

¹Division of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, Yale University School of Medicine, New Haven, Connecticut

,

John W. Devlin

³School of Pharmacy, Northeastern University, Boston, Massachusetts

⁴Division of Pulmonary, Critical Care and Sleep Medicine, Tufts Medical Center, Boston, Massachusetts

,

Yoanna Skrobik

²Department of Medicine, McGill University, Montreal, Quebec, Canada.

› Author Affiliations

Abstract

Managing pain and delirium are crucial to patients, families, and caregivers in intensive care units. The Society of Critical Care Medicine 2018 Pain, Agitation/Sedation, Delirium, Immobility, and Sleep disruption (PADIS) guidelines reviewed literature until October 2015 and made its recommendations for critically-ill adults. This chapter addresses evidence gaps, identified during the guideline process, most relevant to clinicians, adds newer evidence published after the PADIS 2018 guidelines were produced, describes hindsight-driven PADIS process or content-related gaps, and reflects on how these considerations may help inform future research investigations and new guideline efforts.

Keywords

pain - delirium - intensive care - critical care - practice guidelines - knowledge translation

Full Text

References

References
1 Devlin JWSY, Skrobik Y, Gélinas C. , et al. Clinical practice guidelines for the prevention and management of pain, agitation/sedation, delirium, immobility, and sleep disruption in adult patients in the ICU. Crit Care Med 2018; 46 (09) e825-e873
2 Barr J, Fraser GL, Puntillo K. , et al; American College of Critical Care Medicine. Clinical practice guidelines for the management of pain, agitation, and delirium in adult patients in the intensive care unit. Crit Care Med 2013; 41 (01) 263-306
3 Devlin JW, Skrobik Y, Rochwerg B. , et al. Methodologic innovation in creating clinical practice guidelines: insights from the 2018 Society of Critical Care Medicine Pain, Agitation/Sedation, Delirium, Immobility, and Sleep Disruption Guideline Effort. Crit Care Med 2018; 46 (09) 1457-1463
4 Alonso-Coello P, Oxman AD, Moberg J. , et al; GRADE Working Group. GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 2: Clinical practice guidelines. BMJ 2016; 353: i2089
5 Kavanagh BP. The GRADE system for rating clinical guidelines. PLoS Med 2009; 6 (09) e1000094
6 Kumar A, Miladinovic B, Guyatt GH, Schünemann HJ, Djulbegovic B. GRADE guidelines system is reproducible when instructions are clearly operationalized even among the guidelines panel members with limited experience with GRADE. J Clin Epidemiol 2016; 75: 115-118
7 Cousins MJLM, Lynch ME. The Declaration Montreal: access to pain management is a fundamental human right. Pain 2011; 152 (12) 2673-2674
8 Skrobik Y, Flood P. Pain, analgesic effectiveness, and long-term opioid dependency. In: Preiser J-C, Herridge M, Azoulay E. , eds. Post-intensive Care Syndrome. Switzerland: Springer; 2020: 213-222
9 Sjöström B, Jakobsson E, Haljamäe H. Clinical competence in pain assessment. Intensive Crit Care Nurs 2000; 16 (05) 273-282
10 Chanques G, Sebbane M, Barbotte E, Viel E, Eledjam JJ, Jaber S. A prospective study of pain at rest: incidence and characteristics of an unrecognized symptom in surgical and trauma versus medical intensive care unit patients. Anesthesiology 2007; 107 (05) 858-860
11 Rose L, Smith O, Gélinas C. , et al. Critical care nurses' pain assessment and management practices: a survey in Canada. Am J Crit Care 2012; 21 (04) 251-259
12 Watt-Watson J, Stevens B, Garfinkel P, Streiner D, Gallop R. Relationship between nurses' pain knowledge and pain management outcomes for their postoperative cardiac patients. J Adv Nurs 2001; 36 (04) 535-545
13 Glynn G, Ahern M. Determinants of critical care nurses' pain management behaviour. Aust Crit Care 2000; 13 (04) 144-151
14 Coursin DB, Skrobik Y. What is safe sedation in the ICU?. N Engl J Med 2019; 380 (26) 2577-2578
15 Karabinis A, Mandragos K, Stergiopoulos S. , et al. Safety and efficacy of analgesia-based sedation with remifentanil versus standard hypnotic-based regimens in intensive care unit patients with brain injuries: a randomised, controlled trial [ISRCTN50308308]. Crit Care 2004; 8 (04) R268-R280
16 Muellejans B, López A, Cross MH, Bonome C, Morrison L, Kirkham AJ. Remifentanil versus fentanyl for analgesia based sedation to provide patient comfort in the intensive care unit: a randomized, double-blind controlled trial [ISRCTN43755713]. [ISRCTN43755713] Crit Care 2004; 8 (01) R1-R11
17 Dumas EO, Pollack GM. Opioid tolerance development: a pharmacokinetic/pharmacodynamic perspective. AAPS J 2008; 10 (04) 537-551
18 Duceppe MA, Perreault MM, Frenette AJ. , et al. Frequency, risk factors and symptomatology of iatrogenic withdrawal from opioids and benzodiazepines in critically Ill neonates, children and adults: a systematic review of clinical studies. J Clin Pharm Ther 2019; 44 (02) 148-156
19 Breen D, Karabinis A, Malbrain M. , et al. Decreased duration of mechanical ventilation when comparing analgesia-based sedation using remifentanil with standard hypnotic-based sedation for up to 10 days in intensive care unit patients: a randomised trial [ISRCTN47583497]. Crit Care 2005; 9 (03) R200-R210
20 Brook ADAT, Ahrens TS, Schaiff R. , et al. Effect of a nursing-implemented sedation protocol on the duration of mechanical ventilation. Crit Care Med 1999; 27 (12) 2609-2615
21 Rozendaal FWSP, Spronk PE, Snellen FF. , et al; UltiSAFE investigators. Remifentanil-propofol analgo-sedation shortens duration of ventilation and length of ICU stay compared to a conventional regimen: a centre randomised, cross-over, open-label study in the Netherlands. Intensive Care Med 2009; 35 (02) 291-298
22 Strøm T, Martinussen T, Toft P. A protocol of no sedation for critically ill patients receiving mechanical ventilation: a randomised trial. Lancet 2010; 375 (9713): 475-480
23 Robinson BRME, Mueller EW, Henson K, Branson RD, Barsoum S, Tsuei BJ. An analgesia-delirium-sedation protocol for critically ill trauma patients reduces ventilator days and hospital length of stay. J Trauma 2008; 65 (03) 517-526
24 Skrobik Y, Ahern S, Leblanc M, Marquis F, Awissi DK, Kavanagh BP. Protocolized intensive care unit management of analgesia, sedation, and delirium improves analgesia and subsyndromal delirium rates. Anesth Analg 2010; 111 (02) 451-463
25 Faust ACRP, Rajan P, Sheperd LA, Alvarez CA, McCorstin P, Doebele RL. Impact of an analgesia-based sedation protocol on mechanically ventilated patients in a medical intensive care unit. Anesth Analg 2016; 123 (04) 903-909
26 Prin M, Wunsch H. International comparisons of intensive care: informing outcomes and improving standards. Curr Opin Crit Care 2012; 18 (06) 700-706
27 Kumar K, Kirksey MA, Duong S, Wu CL. A review of opioid-sparing modalities in perioperative pain management: methods to decrease opioid use postoperatively. Anesth Analg 2017; 125 (05) 1749-1760
28 Wong I, St John-Green C, Walker SM. Opioid-sparing effects of perioperative paracetamol and nonsteroidal anti-inflammatory drugs (NSAIDs) in children. Paediatr Anaesth 2013; 23 (06) 475-495
29 Subramaniam B, Shankar P, Shaefi S. , et al. Effect of intravenous acetaminophen vs placebo combined with propofol or dexmedetomidine on postoperative delirium among older patients following cardiac surgery: the DEXACET randomized clinical trial. JAMA 2019; 321 (07) 686-696
30 Garber PM, Droege CA, Carter KE, Harger NJ, Mueller EW. Continuous infusion ketamine for adjunctive analgosedation in mechanically ventilated, critically ill patients. Pharmacotherapy 2019; 39 (03) 288-296
31 Dzierba AL, Brodie D, Bacchetta M. , et al. Ketamine use in sedation management in patients receiving extracorporeal membrane oxygenation. Intensive Care Med 2016; 42 (11) 1822-1823
32 Wick EC, Grant MC, Wu CL. Postoperative Multimodal Analgesia Pain Management With Nonopioid Analgesics and Techniques: A Review. JAMA Surg 2017; 152 (07) 691-697
33 American Psychiatric Association. American Psychiatric Association. DSM-5 Task Force. Diagnostic and Statistical Manual of Mental Disorders: DSM-5. Fifth edition. ed:1 online resource (xliv, 947 pages)
34 Pisani MA. Delirium assessment in the intensive care unit: patient population matters. Crit Care 2008; 12 (02) 131
35 Ely EW, Margolin R, Francis J. , et al. Evaluation of delirium in critically ill patients: validation of the Confusion Assessment Method for the Intensive Care Unit (CAM-ICU). Crit Care Med 2001; 29 (07) 1370-1379
36 Bergeron N, Dubois MJ, Dumont M, Dial S, Skrobik Y. Intensive care delirium screening checklist: evaluation of a new screening tool. Intensive Care Med 2001; 27 (05) 859-864
37 Zaal IJ, Devlin JW, Peelen LM, Slooter AJ. A systematic review of risk factors for delirium in the ICU. Crit Care Med 2015; 43 (01) 40-47
38 Inouye SK. Predisposing and precipitating factors for delirium in hospitalized older patients. Dement Geriatr Cogn Disord 1999; 10 (05) 393-400
39 Skrobik Y, Leger C, Cossette M, Michaud V, Turgeon J. Factors predisposing to coma and delirium: fentanyl and midazolam exposure; CYP3A5, ABCB1, and ABCG2 genetic polymorphisms; and inflammatory factors. Crit Care Med 2013; 41 (04) 999-1008
40 Wassenaar A, van den Boogaard M, van Achterberg T. , et al. Multinational development and validation of an early prediction model for delirium in ICU patients. Intensive Care Med 2015; 41 (06) 1048-1056
41 van den Boogaard M, Schoonhoven L, Maseda E. , et al. Recalibration of the delirium prediction model for ICU patients (PRE-DELIRIC): a multinational observational study. Intensive Care Med 2014; 40 (03) 361-369
42 Wassenaar A, Schoonhoven L, Devlin JW. , et al. Delirium prediction in the intensive care unit: comparison of two delirium prediction models. Crit Care 2018; 22 (01) 114
43 Marra A, Pandharipande PP, Shotwell MS. , et al. Acute brain dysfunction: development and validation of a daily prediction model. Chest 2018; 154 (02) 293-301
44 van den Boogaard M, Pickkers P, van der Hoeven H, Roodbol G, van Achterberg T, Schoonhoven L. Implementation of a delirium assessment tool in the ICU can influence haloperidol use. Crit Care 2009; 13 (04) R131
45 Andrews L, Silva SG, Kaplan S, Zimbro K. Delirium monitoring and patient outcomes in a general intensive care unit. Am J Crit Care 2015; 24 (01) 48-56
46 Reade MC, Eastwood GM, Peck L, Bellomo R, Baldwin I. Routine use of the Confusion Assessment Method for the Intensive Care Unit (CAM-ICU) by bedside nurses may underdiagnose delirium. Crit Care Resusc 2011; 13 (04) 217-224
47 Bigatello LM, Amirfarzan H, Haghighi AK. , et al. Effects of routine monitoring of delirium in a surgical/trauma intensive care unit. J Trauma Acute Care Surg 2013; 74 (03) 876-883
48 Pandharipande P, Banerjee A, McGrane S, Ely EW. Liberation and animation for ventilated ICU patients: the ABCDE bundle for the back-end of critical care. Crit Care 2010; 14 (03) 157
49 Marra A, Ely EW, Pandharipande PP, Patel MB. The ABCDEF bundle in critical care. Crit Care Clin 2017; 33 (02) 225-243
50 Patel SB, Poston JT, Pohlman A, Hall JB, Kress JP. Rapidly reversible, sedation-related delirium versus persistent delirium in the intensive care unit. Am J Respir Crit Care Med 2014; 189 (06) 658-665
51 Morandi A, Piva S, Ely EW. , et al. Worldwide survey of the “Assessing Pain, Both Spontaneous Awakening and Breathing Trials, Choice of Drugs, Delirium Monitoring/Management, Early Exercise/Mobility, and Family Empowerment” (ABCDEF) bundle. Crit Care Med 2017; 45 (11) e1111-e1122
52 Devlin JW, Fraser GL, Joffe AM, Riker RR, Skrobik Y. ; Can delirium Assessments Be Accurately Labelled (CABAL) Investigators group. The accurate recognition of delirium in the ICU: the emperor's new clothes?. Intensive Care Med 2013; 39 (12) 2196-2199
53 Khan BA, Perkins AJ, Gao S. , et al. The confusion assessment method for the ICU-7 Delirium Severity Scale: a novel delirium severity instrument for use in the ICU. Crit Care Med 2017; 45 (05) 851-857
54 Devlin JW, Fong JJ, Howard EP. , et al. Assessment of delirium in the intensive care unit: nursing practices and perceptions. Am J Crit Care 2008; 17 (06) 555-565 , quiz 566
55 Rowley-Conwy G. Barriers to delirium assessment in the intensive care unit: A literature review. Intensive Crit Care Nurs 2018; 44: 99-104
56 Wang W, Li HL, Wang DX. , et al. Haloperidol prophylaxis decreases delirium incidence in elderly patients after noncardiac surgery: a randomized controlled trial*. Crit Care Med 2012; 40 (03) 731-739
57 Su X, Meng ZT, Wu XH. , et al. Dexmedetomidine for prevention of delirium in elderly patients after non-cardiac surgery: a randomised, double-blind, placebo-controlled trial. Lancet 2016; 388 (10054): 1893-1902
58 Prakanrattana U, Prapaitrakool S. Efficacy of risperidone for prevention of postoperative delirium in cardiac surgery. Anaesth Intensive Care 2007; 35 (05) 714-719
59 Girard TD, Pandharipande PP, Carson SS. , et al; MIND Trial Investigators. Feasibility, efficacy, and safety of antipsychotics for intensive care unit delirium: the MIND randomized, placebo-controlled trial. Crit Care Med 2010; 38 (02) 428-437
60 Al-Qadheeb NS, Skrobik Y, Schumaker G. , et al. Preventing ICU subsyndromal delirium conversion to delirium with low-dose IV haloperidol: a double-blind, placebo-controlled pilot study. Crit Care Med 2016; 44 (03) 583-591
61 Pandharipande PP, Pun BT, Herr DL. , et al. Effect of sedation with dexmedetomidine vs lorazepam on acute brain dysfunction in mechanically ventilated patients: the MENDS randomized controlled trial. JAMA 2007; 298 (22) 2644-2653
62 van den Boogaard M, Slooter AJC, Brüggemann RJM. , et al; REDUCE Study Investigators. Effect of Haloperidol on survival among critically ill adults with a high risk of delirium: The REDUCE randomized clinical trial. JAMA 2018; 319 (07) 680-690
63 Riker RR, Shehabi Y, Bokesch PM. , et al; SEDCOM (Safety and Efficacy of Dexmedetomidine Compared With Midazolam) Study Group. Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial. JAMA 2009; 301 (05) 489-499
64 Xu JB, Wang YZ, Shi QS. A combined protocol for dexmedetomidine used in prolonged sedation in intensive care unit. Mod Med J Chin 2012; 14: 20-22
65 Srivastava VK, Agrawal S, Kumar S, Mishra A, Sharma S, Kumar R. Comparison of dexmedetomidine, propofol and midazolam for short-term sedation in postoperatively mechanically ventilated neurosurgical patients. J Clin Diagn Res 2014; 8 (09) GC04-GC07
66 Jakob SM, Ruokonen E, Grounds RM. , et al; Dexmedetomidine for Long-Term Sedation Investigators. Dexmedetomidine vs midazolam or propofol for sedation during prolonged mechanical ventilation: two randomized controlled trials. JAMA 2012; 307 (11) 1151-1160
67 MacLaren R, Preslaski CR, Mueller SW. , et al. A randomized, double-blind pilot study of dexmedetomidine versus midazolam for intensive care unit sedation: patient recall of their experiences and short-term psychological outcomes. J Intensive Care Med 2015; 30 (03) 167-175
68 Shehabi Y, Howe BD, Bellomo R. , et al; ANZICS Clinical Trials Group and the SPICE III Investigators. Early sedation with dexmedetomidine in critically ill patients. N Engl J Med 2019; 380 (26) 2506-2517
69 Skrobik Y, Duprey MS, Hill NS, Devlin JW. Low-dose nocturnal dexmedetomidine prevents icu delirium. a randomized, placebo-controlled trial. Am J Respir Crit Care Med 2018; 197 (09) 1147-1156
70 Devlin JW, Roberts RJ, Fong JJ. , et al. Efficacy and safety of quetiapine in critically ill patients with delirium: a prospective, multicenter, randomized, double-blind, placebo-controlled pilot study. Crit Care Med 2010; 38 (02) 419-427
71 Page VJ, Ely EW, Gates S. , et al. Effect of intravenous haloperidol on the duration of delirium and coma in critically ill patients (Hope-ICU): a randomised, double-blind, placebo-controlled trial. Lancet Respir Med 2013; 1 (07) 515-523
72 Skrobik YK, Bergeron N, Dumont M, Gottfried SB. Olanzapine vs haloperidol: treating delirium in a critical care setting. Intensive Care Med 2004; 30 (03) 444-449
73 Needham DM, Colantuoni E, Dinglas VD. , et al. Rosuvastatin versus placebo for delirium in intensive care and subsequent cognitive impairment in patients with sepsis-associated acute respiratory distress syndrome: an ancillary study to a randomised controlled trial. Lancet Respir Med 2016; 4 (03) 203-212
74 Page VJ, Casarin A, Ely EW. , et al. Evaluation of early administration of simvastatin in the prevention and treatment of delirium in critically ill patients undergoing mechanical ventilation (MoDUS): a randomised, double-blind, placebo-controlled trial. Lancet Respir Med 2017; 5 (09) 727-737
75 Girard TD, Exline MC, Carson SS. , et al; MIND-USA Investigators. Haloperidol and ziprasidone for treatment of delirium in critical illness. N Engl J Med 2018; 379 (26) 2506-2516
76 Reade MC, Eastwood GM, Bellomo R. , et al; DahLIA Investigators; Australian and New Zealand Intensive Care Society Clinical Trials Group. Effect of dexmedetomidine added to standard care on ventilator-free time in patients with agitated delirium: a randomized clinical trial. JAMA 2016; 315 (14) 1460-1468
77 O'Mahony R, Murthy L, Akunne A, Young J. ; Guideline Development Group. Synopsis of the national institute for health and clinical excellence guideline for prevention of delirium. Ann Intern Med 2011; 154 (11) 746-751
78 Inouye SK, Westendorp RG, Saczynski JS. Delirium in elderly people. Lancet 2014; 383 (9920): 911-922
79 Fitzgerald JM, Adamis D, Trzepacz PT. , et al. Delirium: a disturbance of circadian integrity?. Med Hypotheses 2013; 81 (04) 568-576
80 Ono H, Taguchi T, Kido Y, Fujino Y, Doki Y. The usefulness of bright light therapy for patients after oesophagectomy. Intensive Crit Care Nurs 2011; 27 (03) 158-166
81 Simons KS, Laheij RJ, van den Boogaard M. , et al. Dynamic light application therapy to reduce the incidence and duration of delirium in intensive-care patients: a randomised controlled trial. Lancet Respir Med 2016; 4 (03) 194-202
82 Taguchi T, Yano M, Kido Y. Influence of bright light therapy on postoperative patients: a pilot study. Intensive Crit Care Nurs 2007; 23 (05) 289-297
83 Black P, Boore JR, Parahoo K. The effect of nurse-facilitated family participation in the psychological care of the critically ill patient. J Adv Nurs 2011; 67 (05) 1091-1101
84 Colombo R, Corona A, Praga F. , et al. A reorientation strategy for reducing delirium in the critically ill. Results of an interventional study. Minerva Anestesiol 2012; 78 (09) 1026-1033
85 Foster J, Kelly M. A pilot study to test the feasibility of a nonpharmacologic intervention for the prevention of delirium in the medical intensive care unit. Clin Nurse Spec 2013; 27 (05) 231-238
86 Moon KJ, Lee SM. The effects of a tailored intensive care unit delirium prevention protocol: A randomized controlled trial. Int J Nurs Stud 2015; 52 (09) 1423-1432
87 Hanison J, Conway D. A multifaceted approach to prevention of delirium on intensive care. BMJ Qual Improv Rep 2015; 4 (01) 4
88 Rivosecchi RM, Kane-Gill SL, Svec S, Campbell S, Smithburger PL. The implementation of a nonpharmacologic protocol to prevent intensive care delirium. J Crit Care 2016; 31 (01) 206-211